PCI complications: Hemodynamic Support for Complex PCI: Difference between revisions

Revision as of 09:28, 7 July 2022

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Anahita Deylamsalehi, M.D.[2]

Class 2b Recommendation, Level of Evidence: B-R^[1]
Using an appropriate hemodynamic support device in the elective settings and among selected patients is reasonable to prevent hemodynamic compromise during PCI.

@@ Line 1: / Line 1: @@
-{{Hemodynamic Support for Complex PC}}
+==Hemodynamic Support for Complex PC==
 {{CMG}}; '''Associate Editors-In-Chief:''' {{Anahita}}
-==Overview==
+===Overview===
+===2021 ACA Revascularization Guideline===
+{|class="wikitable"
+|-
+| colspan="1" style="text-align:center; background:LightGreen"|Class 2b Recommendation, Level of Evidence: B-R<ref name="pmid34895950">{{cite journal| author=Writing Committee Members. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM | display-authors=etal| title=2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=J Am Coll Cardiol | year= 2022 | volume= 79 | issue= 2 | pages= e21-e129 | pmid=34895950 | doi=10.1016/j.jacc.2021.09.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34895950  }} </ref>
+|-
+| bgcolor="LightGreen"|Using an appropriate [[hemodynamic]] support device in the elective settings and among selected [[patients]] is reasonable to [[prevention|prevent]] [[hemodynamic]] compromise during [[PCI]].
+|}